Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clinical Study of the Effect of Intravenous Galactose on Diabetic Macular Oedema

This study has been terminated.
(No sufficient increase in plasma osmolarity by galactose (one patient included))
Sponsor:
Information provided by:
Glostrup University Hospital, Copenhagen
ClinicalTrials.gov Identifier:
NCT00427986
First received: January 25, 2007
Last updated: June 25, 2007
Last verified: June 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2007
  Estimated Primary Completion Date: No date given